Privium Fund Management UK Ltd Purchases New Position in Amedisys, Inc. (NASDAQ:AMED)

Privium Fund Management UK Ltd acquired a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 13,984 shares of the health services provider's stock, valued at approximately $1,284,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Banque Cantonale Vaudoise bought a new position in Amedisys during the first quarter valued at approximately $60,000. Innealta Capital LLC purchased a new position in Amedisys during the second quarter valued at $64,000. Covestor Ltd grew its stake in Amedisys by 134.2% during the first quarter. Covestor Ltd now owns 780 shares of the health services provider's stock valued at $72,000 after acquiring an additional 447 shares in the last quarter. Signaturefd LLC lifted its position in Amedisys by 88.2% during the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock valued at $104,000 after purchasing an additional 530 shares during the last quarter. Finally, Mesirow Institutional Investment Management Inc. lifted its holdings in shares of Amedisys by 9.9% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider's stock worth $270,000 after acquiring an additional 257 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

Shares of AMED stock traded down $0.49 during trading hours on Tuesday, hitting $97.52. The company's stock had a trading volume of 258,271 shares, compared to its average volume of 325,207. The company has a 50 day moving average of $97.44 and a 200 day moving average of $94.51. The stock has a market cap of $3.19 billion, a PE ratio of -152.38, a price-to-earnings-growth ratio of 1.92 and a beta of 0.79. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. Amedisys, Inc. has a 12-month low of $89.55 and a 12-month high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings data on Wednesday, July 24th. The health services provider reported $1.32 EPS for the quarter, beating the consensus estimate of $1.22 by $0.10. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The business had revenue of $591.19 million for the quarter, compared to the consensus estimate of $579.34 million. On average, sell-side analysts forecast that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on AMED shares. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a "buy" rating to a "hold" rating and set a $101.00 price objective for the company. in a report on Monday, July 29th. Cantor Fitzgerald reissued a "neutral" rating and set a $101.00 target price on shares of Amedisys in a research report on Thursday, July 25th. Finally, William Blair downgraded shares of Amedisys from an "outperform" rating to a "market perform" rating in a research report on Monday, July 1st. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.